BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15961997)

  • 1. Nuclear speckles and nucleoli targeting by PIP2-PDZ domain interactions.
    Mortier E; Wuytens G; Leenaerts I; Hannes F; Heung MY; Degeest G; David G; Zimmermann P
    EMBO J; 2005 Jul; 24(14):2556-65. PubMed ID: 15961997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDZ domain-phosphoinositide interactions in cell-signaling.
    Zimmermann P
    Verh K Acad Geneeskd Belg; 2006; 68(4):271-86. PubMed ID: 17214441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characterization of the nuclear dynamics of syntenin-2, a PIP2 binding PDZ protein.
    Geeraerts A; Hsiu-Fang F; Zimmermann P; Engelborghs Y
    Cytometry A; 2013 Sep; 83(9):866-75. PubMed ID: 23300061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syndecan recycling [corrected] is controlled by syntenin-PIP2 interaction and Arf6.
    Zimmermann P; Zhang Z; Degeest G; Mortier E; Leenaerts I; Coomans C; Schulz J; N'Kuli F; Courtoy PJ; David G
    Dev Cell; 2005 Sep; 9(3):377-88. PubMed ID: 16139226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and significance of PDZ domain-phosphoinositide interactions.
    Zimmermann P
    Biochim Biophys Acta; 2006 Aug; 1761(8):947-56. PubMed ID: 16884951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into the PIP2 recognition by syntenin-1 PDZ domain.
    Sugi T; Oyama T; Morikawa K; Jingami H
    Biochem Biophys Res Commun; 2008 Feb; 366(2):373-8. PubMed ID: 18062914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIP(2)-PDZ domain binding controls the association of syntenin with the plasma membrane.
    Zimmermann P; Meerschaert K; Reekmans G; Leenaerts I; Small JV; Vandekerckhove J; David G; Gettemans J
    Mol Cell; 2002 Jun; 9(6):1215-25. PubMed ID: 12086619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1.
    Ohno K; Koroll M; El Far O; Scholze P; Gomeza J; Betz H
    Mol Cell Neurosci; 2004 Aug; 26(4):518-29. PubMed ID: 15276154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The binding of the PDZ tandem of syntenin to target proteins.
    Grembecka J; Cierpicki T; Devedjiev Y; Derewenda U; Kang BS; Bushweller JH; Derewenda ZS
    Biochemistry; 2006 Mar; 45(11):3674-83. PubMed ID: 16533050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tandem PDZ domains of syntenin promote cell invasion.
    Meerschaert K; Bruyneel E; De Wever O; Vanloo B; Boucherie C; Bracke M; Vandekerckhove J; Gettemans J
    Exp Cell Res; 2007 May; 313(9):1790-804. PubMed ID: 17451681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin.
    Grootjans JJ; Reekmans G; Ceulemans H; David G
    J Biol Chem; 2000 Jun; 275(26):19933-41. PubMed ID: 10770943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin.
    Meyer G; Varoqueaux F; Neeb A; Oschlies M; Brose N
    Neuropharmacology; 2004 Oct; 47(5):724-33. PubMed ID: 15458844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Making protein interactions druggable: targeting PDZ domains.
    Dev KK
    Nat Rev Drug Discov; 2004 Dec; 3(12):1047-56. PubMed ID: 15573103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIP2 increases the speed of response of synaptotagmin and steers its membrane-penetration activity toward the plasma membrane.
    Bai J; Tucker WC; Chapman ER
    Nat Struct Mol Biol; 2004 Jan; 11(1):36-44. PubMed ID: 14718921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frizzled 7 and PIP2 binding by syntenin PDZ2 domain supports Frizzled 7 trafficking and signalling.
    Egea-Jimenez AL; Gallardo R; Garcia-Pino A; Ivarsson Y; Wawrzyniak AM; Kashyap R; Loris R; Schymkowitz J; Rousseau F; Zimmermann P
    Nat Commun; 2016 Jul; 7():12101. PubMed ID: 27386966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretory carrier membrane protein SCAMP2 and phosphatidylinositol 4,5-bisphosphate interactions in the regulation of dense core vesicle exocytosis.
    Liao H; Ellena J; Liu L; Szabo G; Cafiso D; Castle D
    Biochemistry; 2007 Sep; 46(38):10909-20. PubMed ID: 17713930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments.
    Zimmermann P; Tomatis D; Rosas M; Grootjans J; Leenaerts I; Degeest G; Reekmans G; Coomans C; David G
    Mol Biol Cell; 2001 Feb; 12(2):339-50. PubMed ID: 11179419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tandem PDZ protein Syntenin interacts with the aminoacyl tRNA synthetase complex in a lysyl-tRNA synthetase-dependent manner.
    Meerschaert K; Remue E; De Ganck A; Staes A; Boucherie C; Gevaert K; Vandekerckhove J; Kleiman L; Gettemans J
    J Proteome Res; 2008 Nov; 7(11):4962-73. PubMed ID: 18839981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntenin: a novel PDZ domain-containing scaffolding protein associated with human melanoma metastasis.
    Yang JB; McCarthy JB
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Apr; 32(2):204-12. PubMed ID: 17478924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lymphocyte receptor CD6 interacts with syntenin-1, a scaffolding protein containing PDZ domains.
    Gimferrer I; Ibáñez A; Farnós M; Sarrias MR; Fenutría R; Roselló S; Zimmermann P; David G; Vives J; Serra-Pagès C; Lozano F
    J Immunol; 2005 Aug; 175(3):1406-14. PubMed ID: 16034076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.